Aviva PLC decreased its position in UnitedHealth Group Inc (NYSE:UNH) by 6.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 759,290 shares of the healthcare conglomerate’s stock after selling 48,835 shares during the period. UnitedHealth Group makes up about 1.1% of Aviva PLC’s portfolio, making the stock its 14th biggest holding. Aviva PLC’s holdings in UnitedHealth Group were worth $202,002,000 at the end of the most recent reporting period.
Other hedge funds have also recently modified their holdings of the company. WoodTrust Financial Corp grew its position in UnitedHealth Group by 2.5% during the 3rd quarter. WoodTrust Financial Corp now owns 7,823 shares of the healthcare conglomerate’s stock worth $2,081,000 after purchasing an additional 189 shares during the period. Advisors Capital Management LLC grew its position in UnitedHealth Group by 15.2% during the 3rd quarter. Advisors Capital Management LLC now owns 1,437 shares of the healthcare conglomerate’s stock worth $382,000 after purchasing an additional 190 shares during the period. Chicago Partners Investment Group LLC grew its position in UnitedHealth Group by 26.5% during the 2nd quarter. Chicago Partners Investment Group LLC now owns 920 shares of the healthcare conglomerate’s stock worth $226,000 after purchasing an additional 193 shares during the period. Highland Capital Management LLC grew its position in UnitedHealth Group by 0.5% during the 3rd quarter. Highland Capital Management LLC now owns 36,128 shares of the healthcare conglomerate’s stock worth $9,612,000 after purchasing an additional 194 shares during the period. Finally, OLD Mutual Customised Solutions Proprietary Ltd. grew its position in UnitedHealth Group by 1.2% during the 2nd quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 17,096 shares of the healthcare conglomerate’s stock worth $4,194,000 after purchasing an additional 200 shares during the period. Institutional investors own 85.57% of the company’s stock.
A number of research firms have recently commented on UNH. Jefferies Financial Group raised their target price on UnitedHealth Group from $270.00 to $311.00 and gave the company a “buy” rating in a research report on Wednesday, October 3rd. Argus raised their target price on UnitedHealth Group to $285.00 and gave the company a “buy” rating in a research report on Thursday, October 18th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $292.00 target price on the stock in a research report on Monday, November 26th. Morgan Stanley raised their target price on UnitedHealth Group from $278.00 to $305.00 and gave the company an “overweight” rating in a research report on Wednesday, September 5th. Finally, ValuEngine upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday, October 2nd. Two equities research analysts have rated the stock with a hold rating and twenty-one have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $292.48.
In related news, Director Richard T. Burke sold 20,000 shares of the firm’s stock in a transaction dated Wednesday, September 12th. The shares were sold at an average price of $263.41, for a total value of $5,268,200.00. Following the transaction, the director now directly owns 1,720,112 shares of the company’s stock, valued at approximately $453,094,701.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Kenneth Irwin Shine sold 163 shares of the firm’s stock in a transaction dated Friday, November 9th. The shares were sold at an average price of $274.83, for a total transaction of $44,797.29. The disclosure for this sale can be found here. Insiders sold a total of 34,395 shares of company stock worth $9,186,302 over the last ninety days. 0.87% of the stock is currently owned by corporate insiders.
Shares of UnitedHealth Group stock opened at $269.18 on Friday. The stock has a market capitalization of $267.97 billion, a P/E ratio of 26.73, a P/E/G ratio of 1.60 and a beta of 0.76. UnitedHealth Group Inc has a twelve month low of $208.48 and a twelve month high of $287.94. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.69 and a current ratio of 0.69.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.30 by $0.11. The firm had revenue of $56.56 billion for the quarter, compared to analyst estimates of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. UnitedHealth Group’s quarterly revenue was up 12.4% compared to the same quarter last year. During the same period last year, the company posted $2.66 EPS. Sell-side analysts forecast that UnitedHealth Group Inc will post 12.82 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 13th. Investors of record on Monday, December 3rd will be paid a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date is Friday, November 30th. UnitedHealth Group’s dividend payout ratio is presently 35.75%.
WARNING: “UnitedHealth Group Inc (UNH) Shares Sold by Aviva PLC” was first published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.thelincolnianonline.com/2018/12/08/unitedhealth-group-inc-unh-shares-sold-by-aviva-plc.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: What is a stock split?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.